Skip to main content
. 2011 Jun;71(6):844–851. doi: 10.1111/j.1365-2125.2010.03858.x

Table 4.

Bleeding time at treatment completion (day 14) in the populations receiving placebo or terutroban at 2.5, 5 or 10 mg day−1

Placebo (n = 12) Terutroban 2.5 mg day1(n = 11) Terutroban 5 mg day1(n = 12) Terutroban 10 mg day1(n = 12)
Bleeding time (min) 6.63 ± 1.86 5.55 ± 1.42 7.25 ± 3.75 7.21 ± 2.04

Values are means ± SD.